6034
MRT Inc.
MRT株式会社MRT Inc. operates a medical information platform. It provides Gaikin, a recruitment service specializing in part-time physicians; career, a job change support service for doctors; re:ray, a one stop outsourcing service; Door., an app to connect network of doctors; Door.into, an app platform that connects doctors and medical institutions with individuals; Pocket Doctor, a telemedicine app; groupware for medical departments; and FASTCALL a safety confirmation service for medical institutions consolidating the functions for hospital crisis management systems. The company also offers stem cell culture supernatant for medical institutions; pharmacist, clinical engineering technician, radiologic technologists, dialysis nurses, new practice openings and succession cases, clinical laboratory technician, and nurse recruitment services; job posting service for full-time and part-time industrial physicians; occupational health services; employment placement services; life support services; and full-time, part-time, and temporary positions for healthcare and welfare professionals. In addition, it engages in book publishing on illness and treatment; medical worker job placement business; business start-up; business succession support business; PR services, comprehensive membership compensation system, tax accountant referral services, and human umbilical cord-derived culture supernatant. Further, it offers anew, a service aimed at payroll calculation for doctors part-time jobs and payroll transfer agency services; Medikiki, an information distribution platform connecting manufacturers and wholesalers; and Kids Line that provides babysitting services. MRT Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Price
¥635
Market Cap
¥3.5B
Ent. Value
¥2.0B
Net Cash
¥1.5B
Shares Out.
5.5M
P / E
64.1×
EV / EBIT
21.1×
P / Book
—
P / NCAV
3.31×
Div. Yield
—
Financials
| Metric |
FY 2025
EDINET ↗ |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|---|
| Net Sales | ¥4.2B | ¥4.2B | ¥5.4B | ¥8.7B | ¥4.5B |
| Cost of Sales | ¥1.3B | ¥1.4B | ¥1.9B | ¥3.1B | ¥916M |
| Gross Profit | ¥2.8B | ¥2.7B | ¥3.5B | ¥5.6B | ¥3.6B |
| SG&A | ¥2.8B | ¥2.8B | ¥2.5B | ¥2.6B | ¥2.1B |
| Operating Income | ¥96M | ¥-120M | ¥834M | ¥3.0B | ¥1.3B |
| Non-Operating Income | ¥29M | ¥7M | ¥40M | ¥1M | ¥1M |
| Non-Operating Expenses | ¥16M | ¥8M | ¥7M | ¥42M | ¥13M |
| Interest Expense | ¥12M | ¥8M | ¥7M | ¥11M | ¥12M |
| Pre-tax Income | ¥109M | ¥-332M | ¥858M | ¥2.9B | ¥1.3B |
| Net Income (owners) | ¥56M | ¥-309M | ¥517M | ¥2.2B | ¥774M |
| Minority Interest | ¥-6M | ¥-27M | ¥22M | ¥22M | ¥30M |
| Comprehensive Income | ¥315M | ¥-306M | ¥543M | ¥2.2B | ¥736M |
| EBITDA | ¥343M | ¥139M | ¥1.1B | ¥3.2B | ¥1.4B |
| EPS | ¥9.91 | ¥-56.55 | ¥94.43 | ¥387.53 | ¥139.30 |
| Shares Outstanding | 5.5M | 5.7M | 5.4M | 5.6M | 5.6M |
| Shares Issued (total) | 5.7M | 5.7M | 5.7M | 5.7M | 5.7M |
| Treasury Shares | 0.2M | 0.0M | 0.3M | 0.1M | 0.1M |